The next generation depends on it. Here are five potential endgames.
The next generation depends on it. Here are five potential endgames.
The energy-drink industry is growing sales at 15% a year, the fastest in the beverage aisle. But competition is fierce, with each brand staking a claim to niche consumers.
It’s a high-voltage stopgap that just might save the artificial-intelligence buildout.
The streamer was once the prime example of modern entertainment. Now it’s being squeezed by Big Tech and user-generated content. What stock investors need to know.
Corporate insurgencies hit a fever pitch this month—and October is only half over. We break down, and size up, five of the biggest dramas.
The S&P 500’s yield is pathetic, at about 1%. But there are plenty of new members in its high-dividend-yielders club.
Meta Platforms’ Muse and other AI assistants are gaining momentum fast. Here’s how they work—and why Apple might have to worry.
Comcast and Charter Communications are facing stiff competition in broadband from telecoms. Who’s the big winner?
As more workers treat AI like a true assistant, productivity will rise and boost economic growth. Plus, outside-the-box ways to predict company performance.
With products ranging from cardboard boxes to new drugs, these companies are all on track to double their earnings.
Most investors can benefit from simple indexing. But for better diversification and ballast, here are some add-ons.
Why EPR Properties, which specializes in unusual assets—such as the Great Escape theme park, with its 99-year-old Comet coaster—is riding higher this year.
The view that 5% on the 10-year Treasury is a tipping point for stocks is too simplistic. But consider tapping into some of today’s fat yields anyway.
The discount chain doesn’t get the respect of its bigger rival, but there’s much for a shopper to love. And here’s why Wall Street should love it, too.
Coca-Cola stock has raced ahead of PepsiCo this year. It all has to do with the mysteries of taste.
This blockbuster class of drugs is shattering all sales records. Which stock will do better—Eli Lilly or Novo Nordisk?
Second-quarter earnings growth is up by 25%, and could go even higher. Why aren’t stocks keeping up?
The S&P 500 is suddenly lagging behind other indexes, bringing rewards for investors who stuck with international, small-caps, and other parts of the stock market.
Perpetual futures contracts are complicated—and are often used with extreme leverage. You’re right to be wary.
It once was as hot as Amazon and Apple. Now it’s one of the 10 worst-performing stocks in the S&P 500.
of 71 pages